News on this topic
Pfizer earnings strong despite Trump’s new 'up to 250%' tariff threat
Pfizer earnings strong despite Trump’s new 'up to 250%' tariff threat: Pfizer beat earnings expectations and improved its outlook for the rest of the year ...
l.euronews.com/J8tF
Pfizer raises 2025 profit forecast as cost-cutting program gains traction
Pfizer raises 2025 profit forecast as cost-cutting program gains traction: Pfizer said its full-year profit should benefit from cost cuts across its research and ...
reuters.com/business/healthcare-pharmaceuticals/pfizer-raises-2025-profit-forecast-cost-cutting-program-gains-traction-2025-08-05/
Pfizer hikes 2025 profit outlook on cost cuts, strong quarterly results
Pfizer hikes 2025 profit outlook on cost cuts, strong quarterly results: The results come as Pfizer and other drugmakers grapple with Trump's calls to lower U.S ...
cnbc.com/2025/08/05/pfizer-pfe-q2-2025-earnings-report.html
More articles on this subject
BioNTech partner Pfizer beats expectations – forecast raised
BioNTech partner Pfizer beats expectations – forecast raised: Pfizer exceeds expectations with Q2 sales of $14.7 billion and raises its profit forecast for 2025.
deraktionaer.de/artikel/pharma-biotech/biontech-partner-pfizer-schlaegt-die-erwartungen-prognose-rauf-20384390.html
Similar to This
Pfizer offshoot Zoetis lines up 'potential blockbuster' pet meds for Japan
Pfizer offshoot Zoetis lines up 'potential blockbuster' pet meds for Japan: TOKYO -- The market for cancer and chronic illness treatments for pets is growing in ...
asia.nikkei.com/business/pharmaceuticals/pfizer-offshoot-zoetis-lines-up-potential-blockbuster-pet-meds-for-japan
Among ~294,000 US veterans aged 65+, Moderna's next-gen mRNA-1283 COVID-19 ...
Among ~294,000 US veterans aged 65+, Moderna's next-gen mRNA-1283 COVID-19 vaccine was associated with 36% lower risk of medically attended COVID-19 and 47% ...
jamanetwork.com/journals/jamanetworkopen/fullarticle/2856471
20,000 Australian Students Lacked Informed COVID Vaccine Consent
20,000 Australian Students Lacked Informed COVID Vaccine Consent: Australia’s New South Wales Health Department apologised after acknowledging that more than 20 ...
greekcitytimes.com/2026/10/31/20000-australian-students-lacked-informed-covid-vaccine-consent/
Polish air-traffic agency funds frozen as Pfizer enforces €1 ...
Polish air-traffic agency funds frozen as Pfizer enforces €1.3bn ruling for Poland's unpaid Covid vaccines
notesfrompoland.com/2026/07/11/polish-air-traffic-agency-funds-frozen-as-pfizer-enforces-e1-3bn-ruling-for-polands-unpaid-covid-vaccines/
Pfizer does deal with Trump on prescription drug prices
Pfizer does deal with Trump on prescription drug prices: Pfizer and President Donald Trump said they had cut a deal in which the U.S.-based drugmaker agreed to ...
reuters.com/business/healthcare-pharmaceuticals/trump-announce-pfizer-drug-price-cuts-2025-09-30/
Pfizer, Moderna shares fall on report that Trump officials will link child ...
Pfizer, Moderna shares fall on report that Trump officials will link child deaths to Covid shots
cnbc.com/2025/09/12/pfizer-moderna-shares-fall-on-trump-child-covid-shot-report.html
Stocks Rally on Apple Strength: Stock Market Today
Stocks Rally on Apple Strength: Stock Market Today : The iPhone maker will boost its U.S. investment by $100 billion, which sent the Dow Jones stock soaring.
kiplinger.com/investing/stocks/stocks-rally-on-apple-strength-stock-market-today
Pfizer boosts profit estimate, even as the drug giant absorbs tariffs
Pfizer boosts profit estimate, even as the drug giant absorbs tariffs: Pfizer’s stock rallies after drug giant cites strength in its COVID-19 drugs and Vyndaqel ...
marketwatch.com/story/pfizer-boosts-2025-profit-estimate-in-a-sign-of-confidence-b53242ae
Pfizer invests $1 billion in new pharmaceutical ingredient plant in ...
Pfizer invests $1 billion in new pharmaceutical ingredient plant in Singapore, creating 250 jobs
straitstimes.com/business/pfizer-invests-1-billion-in-new-pharmaceutical-ingredient-plant-in-singapore-creating-250-new-jobs
Key FactsPfizer Launches Advanced Manufacturing Plant in Singapore
Jul 23, 2024 · Reading time: ~45 sec.
Summary created with AI assistance · Source: straitstimes.com
  • Pfizer officially opened a $1 billion plant in Singapore producing active pharmaceutical ingredients for cancer and antibiotic drugs.

  • The new facility is an extension of Pfizer’s two-decade presence and has begun commercial manufacturing after final checks.

  • It earned a Green Mark gold certification reflecting its environmental sustainability efforts aligned with net-zero goals by 2040.

  • This investment enhances Singapore’s biomedical sector and generates 250 high-skilled positions within the advanced manufacturing hub.
  • This expanded facility not only grows our overall manufacturing footprint, but also strengthens our ability to manufacture breakthrough medicine that change patients’ lives.
    — Mike McDermott, Chief Global Supply Officer of Pfizer, speaking at the opening ceremony.
Pfizer: double blow before the numbers - that is expected
Pfizer: double blow before the numbers - that is expected: Two approvals in a short time.
deraktionaer.de/artikel/pharma-biotech/pfizer-doppelschlag-vor-den-zahlen-das-wird-erwartet-20356527.html
Key FactsPfizer announces two approvals before quarterly results
Apr 30, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: deraktionaer.de
  • At the start of the week, the FDA approved Tivdak for recurrent or metastatic cervical cancer.

  • Tivdak contains tisotumab vedotin, an antibody-drug conjugate Pfizer acquired through its takeover of Seagen.

  • The previous week, the FDA approved Beqvez for adults with hemophilia B; the gene therapy costs $3.5 million.

  • On average, analysts expect $13.9 billion revenue, $3.97 billion EBIT, and earnings of $0.31 or adjusted $0.52 per share on May 8.